{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-064545","form_type":"8-K","ticker":"PMN","cik":"0001374339","company_name":"ProMIS Neurosciences Inc.","filed_at":"2026-05-20T20:30:26+00:00","discovered_at":"2026-05-20T20:32:00.246717+00:00","generated_at":"2026-05-20T20:51:56.936820+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Shareholders approve increase in stock option plan shares by 900,000 at 2026 annual meeting","bullets":["All 7 director nominees elected; broker non-votes of 614,643.","Ratification of Baker Tilly as auditor approved: 4,657,634 for, 4,415 against.","Amendment to 2025 Plan increases shares available to 1,017,868 from 117,868.","Shareholders representing 53.1% of outstanding common shares present at meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-064545","json":"https://secwatch.observer/filing/0001104659-26-064545.json","markdown":"https://secwatch.observer/filing/0001104659-26-064545.md","text":"https://secwatch.observer/filing/0001104659-26-064545.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374339/000110465926064545/0001104659-26-064545-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374339/000110465926064545/pmn-20260520x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T20:51:56.936820+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}